Difficulties in the prevention of cervical cancer: Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary

Erika Marek, Timea Dergez, Antal Kricskovics, Krisztina Kovacs, Gabor Rebek-Nagy, Katalin Gocze, Istvan Kiss, I. Ember, Peter Gocze

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

Cervical cancer is one of the most prevalent gynaecological malignancies worldwide. The Hungarian incidence and mortality of this disease take the 4th-5th places within the European Union. A survey including 785 male and female adults was conducted to assess the knowledge and attitudes concerning HPV vaccination. We focused on the difficulties of the primary and secondary prevention of cervical cancer and examined some potential sociodemographic predictors of HPV vaccine acceptability.Our findings have identified some important issues like: incomplete knowledge, intense distrust and financial concerns. Almost half of the college students (45.6%) are unaware of HPV infections. We confirmed previous findings that older age and female gender correlates with better knowledge on STDs, including HPV. We found that greater exposure to health information comes with better knowledge and more positive attitudes towards vaccination.One quarter of survey respondents do not believe that cervical cancer may be prevented by vaccination. More than half of the adults do not trust national health care system and the preparedness of Hungarian doctors. General attitudes towards vaccination are broadly positive, 80% of survey participants had expressed desire towards HPV vaccination, however if there was a need to pay for the vaccination the willingness would decrease by half.Primary prevention through HPV-focused educational programs, clear communication and financial support would be important for public health to reduce the high incidence and mortality of cervical cancer in Hungary in the future.

Original languageEnglish
Pages (from-to)5122-5129
Number of pages8
JournalVaccine
Volume29
Issue number32
DOIs
Publication statusPublished - Jul 18 2011

Fingerprint

uterine cervical neoplasms
Hungary
Uterine Cervical Neoplasms
Vaccination
Vaccines
vaccination
vaccines
Primary Prevention
health information
Financial Support
Papillomavirus Vaccines
incidence
Mortality
Incidence
European Union
Sexually Transmitted Diseases
communication (human)
Secondary Prevention
college students
education programs

Keywords

  • Acceptability
  • Adults
  • Awareness
  • Cervical cancer
  • HPV
  • Knowledge
  • Survey
  • Vaccine

ASJC Scopus subject areas

  • Immunology and Microbiology(all)
  • Infectious Diseases
  • Public Health, Environmental and Occupational Health
  • veterinary(all)
  • Molecular Medicine

Cite this

Difficulties in the prevention of cervical cancer : Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary. / Marek, Erika; Dergez, Timea; Kricskovics, Antal; Kovacs, Krisztina; Rebek-Nagy, Gabor; Gocze, Katalin; Kiss, Istvan; Ember, I.; Gocze, Peter.

In: Vaccine, Vol. 29, No. 32, 18.07.2011, p. 5122-5129.

Research output: Contribution to journalArticle

Marek, E, Dergez, T, Kricskovics, A, Kovacs, K, Rebek-Nagy, G, Gocze, K, Kiss, I, Ember, I & Gocze, P 2011, 'Difficulties in the prevention of cervical cancer: Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary', Vaccine, vol. 29, no. 32, pp. 5122-5129. https://doi.org/10.1016/j.vaccine.2011.05.048
Marek, Erika ; Dergez, Timea ; Kricskovics, Antal ; Kovacs, Krisztina ; Rebek-Nagy, Gabor ; Gocze, Katalin ; Kiss, Istvan ; Ember, I. ; Gocze, Peter. / Difficulties in the prevention of cervical cancer : Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary. In: Vaccine. 2011 ; Vol. 29, No. 32. pp. 5122-5129.
@article{3d543918899340d7a673ccbe8c304211,
title = "Difficulties in the prevention of cervical cancer: Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary",
abstract = "Cervical cancer is one of the most prevalent gynaecological malignancies worldwide. The Hungarian incidence and mortality of this disease take the 4th-5th places within the European Union. A survey including 785 male and female adults was conducted to assess the knowledge and attitudes concerning HPV vaccination. We focused on the difficulties of the primary and secondary prevention of cervical cancer and examined some potential sociodemographic predictors of HPV vaccine acceptability.Our findings have identified some important issues like: incomplete knowledge, intense distrust and financial concerns. Almost half of the college students (45.6{\%}) are unaware of HPV infections. We confirmed previous findings that older age and female gender correlates with better knowledge on STDs, including HPV. We found that greater exposure to health information comes with better knowledge and more positive attitudes towards vaccination.One quarter of survey respondents do not believe that cervical cancer may be prevented by vaccination. More than half of the adults do not trust national health care system and the preparedness of Hungarian doctors. General attitudes towards vaccination are broadly positive, 80{\%} of survey participants had expressed desire towards HPV vaccination, however if there was a need to pay for the vaccination the willingness would decrease by half.Primary prevention through HPV-focused educational programs, clear communication and financial support would be important for public health to reduce the high incidence and mortality of cervical cancer in Hungary in the future.",
keywords = "Acceptability, Adults, Awareness, Cervical cancer, HPV, Knowledge, Survey, Vaccine",
author = "Erika Marek and Timea Dergez and Antal Kricskovics and Krisztina Kovacs and Gabor Rebek-Nagy and Katalin Gocze and Istvan Kiss and I. Ember and Peter Gocze",
year = "2011",
month = "7",
day = "18",
doi = "10.1016/j.vaccine.2011.05.048",
language = "English",
volume = "29",
pages = "5122--5129",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",
number = "32",

}

TY - JOUR

T1 - Difficulties in the prevention of cervical cancer

T2 - Adults' attitudes towards HPV vaccination 3 years after introducing the vaccine in hungary

AU - Marek, Erika

AU - Dergez, Timea

AU - Kricskovics, Antal

AU - Kovacs, Krisztina

AU - Rebek-Nagy, Gabor

AU - Gocze, Katalin

AU - Kiss, Istvan

AU - Ember, I.

AU - Gocze, Peter

PY - 2011/7/18

Y1 - 2011/7/18

N2 - Cervical cancer is one of the most prevalent gynaecological malignancies worldwide. The Hungarian incidence and mortality of this disease take the 4th-5th places within the European Union. A survey including 785 male and female adults was conducted to assess the knowledge and attitudes concerning HPV vaccination. We focused on the difficulties of the primary and secondary prevention of cervical cancer and examined some potential sociodemographic predictors of HPV vaccine acceptability.Our findings have identified some important issues like: incomplete knowledge, intense distrust and financial concerns. Almost half of the college students (45.6%) are unaware of HPV infections. We confirmed previous findings that older age and female gender correlates with better knowledge on STDs, including HPV. We found that greater exposure to health information comes with better knowledge and more positive attitudes towards vaccination.One quarter of survey respondents do not believe that cervical cancer may be prevented by vaccination. More than half of the adults do not trust national health care system and the preparedness of Hungarian doctors. General attitudes towards vaccination are broadly positive, 80% of survey participants had expressed desire towards HPV vaccination, however if there was a need to pay for the vaccination the willingness would decrease by half.Primary prevention through HPV-focused educational programs, clear communication and financial support would be important for public health to reduce the high incidence and mortality of cervical cancer in Hungary in the future.

AB - Cervical cancer is one of the most prevalent gynaecological malignancies worldwide. The Hungarian incidence and mortality of this disease take the 4th-5th places within the European Union. A survey including 785 male and female adults was conducted to assess the knowledge and attitudes concerning HPV vaccination. We focused on the difficulties of the primary and secondary prevention of cervical cancer and examined some potential sociodemographic predictors of HPV vaccine acceptability.Our findings have identified some important issues like: incomplete knowledge, intense distrust and financial concerns. Almost half of the college students (45.6%) are unaware of HPV infections. We confirmed previous findings that older age and female gender correlates with better knowledge on STDs, including HPV. We found that greater exposure to health information comes with better knowledge and more positive attitudes towards vaccination.One quarter of survey respondents do not believe that cervical cancer may be prevented by vaccination. More than half of the adults do not trust national health care system and the preparedness of Hungarian doctors. General attitudes towards vaccination are broadly positive, 80% of survey participants had expressed desire towards HPV vaccination, however if there was a need to pay for the vaccination the willingness would decrease by half.Primary prevention through HPV-focused educational programs, clear communication and financial support would be important for public health to reduce the high incidence and mortality of cervical cancer in Hungary in the future.

KW - Acceptability

KW - Adults

KW - Awareness

KW - Cervical cancer

KW - HPV

KW - Knowledge

KW - Survey

KW - Vaccine

UR - http://www.scopus.com/inward/record.url?scp=79960301148&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79960301148&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2011.05.048

DO - 10.1016/j.vaccine.2011.05.048

M3 - Article

C2 - 21624417

AN - SCOPUS:79960301148

VL - 29

SP - 5122

EP - 5129

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 32

ER -